In 2021, A-share R&D expenses will exceed 1,200 billion yuan, and pharmaceutical and biological companies are "most invested"_Shenzhen Hotline

  • Post date May 6, 2022 — 11:48 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

002405 002689 300033 300204 300297 300333 300454 300530 300713 300799 Beijing Zuojiang Technology Bluedon Information Security Technologies Guangdong Dazhi Environmental Protection Technologyorporated Company Hithink Royalflush Information Network Hundsun Technologies Navinfo Sangfor Technologies Shenyang Yuanda Intellectual Industry Group Shenzhenrease Technology Sinosun Technology Staidson (Beijing) Biopharmaceuticals Science, Technology Accounting, Audit Restructuring, Recapitalisation Research, Development Pharmaceutical Electricity Production, Distribution Financial, Business Service Market, Exchange Securities Stocks Medicine Trend Biotechnology Biology Technology, Engineering

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data